Chai Discovery, a nascent AI-driven biology startup, has secured nearly $30 million in funding from prominent investors Thrive Capital and OpenAI. Founded just six months ago, Chai aims to revolutionize drug discovery by utilizing AI to predict the structure of biochemical molecules and manipulate their interactions, a critical step in developing new medications.
Joshua Meier, the company’s…
